[Retracted] Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma

Figure 4

Validation of the MSRS as a predicting factor for worse prognosis in two additional datasets. (a) GSEA results confirming the prognostic value of the MSRS in the GSE76427 dataset (). (b) Comparison of MSRS scores between patients of the GSE76427 dataset who were alive () or dead () during follow-up. (c) Kaplan–Meier plot indicating the survival probabilities of HCC patients of the GSE76427 dataset stratified by their MSRS scores. (d) GSEA results confirming the prognostic value of the MSRS in TCGA-LIHC dataset (). (e) Comparison of MSRS scores between patients of TCGA-LIHC dataset who were alive () or dead () during follow-up. (f) Kaplan–Meier plot indicating the survival probabilities of HCC patients of TCGA-LIHC dataset stratified by their MSRS scores. (g) Kaplan–Meier plot indicating the survival probabilities (<6 years) of HCC patients of TCGA-LIHC dataset stratified by their MSRS scores. (h) Multivariate Cox regression analysis for the validation of the MSRS as a risk factor in TCGA-LIHC dataset (only the parameters relative to the first 6 years were included).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)